Korea United to patent Atenolol soft capsule.

Published: 2006-03-14 06:57:00

Updated: 2006-03-14 06:57:00

Korea United Pharm. Co. announced on March 9 that a patent for a soft encapsulation of atenolol, a beta-blocker anti-hypertension drug, was completed to register in Korea.

The company explained the patent claims characterized in which atenolol was dissolved in excipients dispensed with one or...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK